Daily Cosmetic Research Analysis
Three impactful studies at the cosmetic-health interface emerged today: a meta-analysis suggests fluoride mouthrinses add limited benefit for preventing initial caries during fixed orthodontic treatment when toothpaste is used; a systematic review finds no significant association between cosmetic-related endocrine disruptors (phthalates/parabens) and gestational diabetes; and a midterm cohort shows radiofrequency ablation provides durable symptom and cosmetic improvement for multinodular goiter.
Summary
Three impactful studies at the cosmetic-health interface emerged today: a meta-analysis suggests fluoride mouthrinses add limited benefit for preventing initial caries during fixed orthodontic treatment when toothpaste is used; a systematic review finds no significant association between cosmetic-related endocrine disruptors (phthalates/parabens) and gestational diabetes; and a midterm cohort shows radiofrequency ablation provides durable symptom and cosmetic improvement for multinodular goiter.
Research Themes
- Caries prevention during orthodontic treatment
- Safety of cosmetic-related endocrine disruptors in pregnancy
- Cosmetic outcomes of minimally invasive endocrine interventions
Selected Articles
1. Fluoride mouthrinses for prevention of initial caries in orthodontic patients - a systematic review and meta-analysis.
Across seven RCTs (n=704), fluoride mouthrinses added to daily fluoride toothpaste use produced a small absolute risk reduction (risk difference −0.07; 95% CI −0.14 to −0.01) in initial caries adjacent to brackets. Given heterogeneity and moderate-to-high risk of bias, the authors conclude there is insufficient evidence to recommend routine FMR during fixed orthodontics, though selected high-risk patients may benefit.
Impact: Challenges a common prophylactic recommendation by quantifying the modest additive benefit of fluoride mouthrinses during orthodontic treatment with rigorous synthesis of RCTs.
Clinical Implications: Do not routinely prescribe fluoride mouthrinses for all fixed-appliance patients already using fluoride toothpaste; reserve for patients at elevated caries risk after individualized assessment, and standardize protocols in future practice and trials.
Key Findings
- Seven RCTs (n=704) met inclusion; five entered meta-analysis.
- Pooled risk difference for initial caries near bracket bases was −0.07 (95% CI −0.14 to −0.01) favoring fluoride mouthrinses.
- All studies used fluoride toothpaste as baseline care; FMR frequency ranged from twice daily to twice weekly over 6–26 months.
- Risk of bias was moderate in five studies and high in two, limiting certainty.
- Authors conclude insufficient support for general FMR recommendation; potential benefits may exist for selected high-risk patients.
Methodological Strengths
- Comprehensive multi-database search with predefined inclusion criteria and risk-of-bias assessment
- Random-effects meta-analysis of RCTs with subject-level caries outcomes
Limitations
- Heterogeneity in rinse frequency, duration, and outcome reporting across trials
- Moderate-to-high risk of bias in included studies with limited number eligible for meta-analysis
Future Directions: Conduct adequately powered, low-bias RCTs with standardized FMR regimens and a core outcome set to identify subgroups who benefit most.
BACKGROUND: Orthodontic patients are often instructed to use fluoride mouthrinses (FMR) to prevent caries during treatment with fixed orthodontic appliances (FOA). The aim of this study was to examine the caries preventive effect of FMR during FOA treatment based on randomized controlled trials. METHODS: An information specialist searched five databases up to September 30, 2024. We included trials with parallel groups (intervention vs. control) and a minimum duration of six months. Based on the abstracts, the authors independently selected and reviewed full text papers, extracted key outcome data, and assessed the risk of bias. The primary outcome was incidence of enamel caries on subject level. We conducted a narrative synthesis and pooled comparable data in a random effects model. RESULTS: We identified 22 studies of which seven, involving 704 patients, met the inclusion criteria. Five and two studies had moderate and high risk of bias, respectively. In all studies, FMR was additive to daily use of fluoride toothpaste. The intervention varied from twice daily to twice weekly and the duration ranged from six to 26 months. Five studies were included in a meta-analysis. The aggregated data showed a small risk difference of - 0.07 (95% CI -0.14; -0.01) in initial caries development adjacent to bracket base between the experimental and the control groups. CONCLUSION: This review found insufficient support for a general recommendation to use FMR during treatment with fixed orthodontic appliances in populations with regular use of fluoride toothpaste. This does not rule out the possibility that individual orthodontic patients may benefit from FMR after comprehensive risk assessment. Further investigations with standardized interventions and duration, reporting a core outcome set are required to clarify the effectiveness of fluoride mouthrinses in orthodontic patients.
2. Maternal exposure to specific endocrine-disrupting chemicals and gestational diabetes mellitus: systematic review and meta-analysis.
Pooling 14 studies (n=9,503), maternal exposure to phthalates showed no significant association with gestational diabetes risk (OR 1.01; 95% CI 0.95–1.08), and limited data on parabens also did not support a link. Results were consistent across geographic and metabolite subgroup analyses.
Impact: Addresses widespread concern about cosmetic-related endocrine disruptors in pregnancy by synthesizing current evidence and finding no significant association with GDM, guiding risk communication and research priorities.
Clinical Implications: Clinicians can reassure patients that current evidence does not support a link between maternal phthalate/paraben exposure and GDM, while still advising prudent minimization of unnecessary exposures and prioritizing overall metabolic risk management.
Key Findings
- Fourteen studies (9,503 participants) were synthesized after systematic database searches.
- Pooled OR for phthalate exposure and GDM was 1.01 (95% CI 0.95–1.08), indicating no significant association.
- Subgroup analyses by geography and specific phthalate metabolites also showed no significant associations.
- Limited evidence for parabens did not demonstrate a clear link to GDM.
- Most included studies were rated high quality (11 high-quality, 3 acceptable).
Methodological Strengths
- Systematic multi-database search with predefined inclusion and quality appraisal
- Subgroup analyses by geography and metabolites; biospecimen-based exposure assessment (urine/serum/plasma)
Limitations
- Observational designs susceptible to residual confounding and exposure misclassification
- Limited data on parabens and potential mixture effects; heterogeneity in timing and metrics of exposure
Future Directions: Prospective cohorts with repeated measures, mixture modeling, and mechanistic endpoints to elucidate cumulative and long-term effects during pregnancy.
This meta-analysis examines the relationship between exposure to endocrine-disrupting chemicals, such as phthalates and parabens, which are commonly found in cosmetics, and the risk of developing gestational diabetes mellitus (GDM). Following a systematic search of databases (including PubMed, Scopus, and Web of Science), 14 relevant studies involving 9,503 pregnant women from various regions were identified. After excluding one paper, 11 studies were classified as high-quality, while three received acceptable scores and were included in the analysis. The studies assessed the level of chemical exposure by analyzing urine, serum, or plasma samples. Calculated odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the potential association between maternal exposure and GDM development. The pooled analysis indicated no significant correlation between phthalate exposure during pregnancy and GDM risk, with an OR of 1.01 (95% CI: 0.95-1.08). Subgroup analyses based on participants' location and specific phthalate metabolites consistently showed no significant association with GDM. Limited evidence on parabens also failed to demonstrate a clear link with GDM. Although this meta-analysis found no significant link between these substances and GDM, further investigation is necessary to comprehensively assess the cumulative and long-term effects of endocrine-disrupting chemicals on pregnant women.
3. Radiofrequency Ablation in the Management of Extensive Multinodular Goiter: A Midterm Single-Center Experience.
In a retrospective single-center cohort (40 patients; 175 nodules), monopolar RF ablation achieved a mean 85.3% volume reduction at a mean 40.5-month follow-up, with significant improvement in symptom and cosmetic scores and a low rate of temporary hoarseness (7.5%). Many patients required only one session, and surgery was avoided in selected cases.
Impact: Demonstrates durable, clinically meaningful symptom and cosmetic benefits of RF ablation for extensive multinodular goiter, supporting a minimally invasive alternative to thyroidectomy.
Clinical Implications: Consider RF ablation for selected multinodular goiter patients prioritizing cosmetic outcomes or surgical avoidance; counsel regarding possible need for staged sessions and transient voice changes.
Key Findings
- Mean nodule volume reduction rate was 85.3% at a mean 40.5-month follow-up.
- Symptom scores improved from 2.9 to 0.3 and cosmetic scores from 3.6 to 1.6 (both P < .001).
- A single RFA session treated 134 nodules; additional sessions addressed planned nodules, incomplete ablation, or new/growing lesions.
- Temporary hoarseness occurred in 7.5% of patients; no other adverse events were reported.
Methodological Strengths
- Midterm follow-up with both clinical and imaging endpoints capturing symptom and cosmetic outcomes
- Real-world cohort including multiple nodules per patient with documented reasons for retreatment
Limitations
- Retrospective single-center design without a surgical or observation comparator
- Modest sample size and potential selection bias
Future Directions: Prospective comparative trials versus surgery and other ablative modalities incorporating quality-of-life, cost-effectiveness, and long-term regrowth outcomes.
PURPOSE: To assess the effectiveness of radiofrequency (RF) ablation in providing cosmetic and symptom relief for patients with extensive multinodular goiter. MATERIALS AND METHODS: This retrospective study included 40 patients (175 target nodules, averaging 4 per patient) treated with monopolar RF ablation. Effectiveness was assessed through clinical symptom relief, laboratory tests, and ultrasound (US) monitoring of target and nontarget lesions. RESULTS: A single RF ablation session was sufficient for 134 nodules (24 patients), whereas 19 additional sessions were performed in 13 patients for 41 additional lesions. Reasons for repeated RF ablation included planned treatment of additional nodules (n = 32, 12 patients), retreatment due to incomplete ablation (n = 6, 4 patients), treatment of growing nontarget lesions (n = 2, 2 patients), and new nodules (n = 1, 1 patient). At the last follow-up (mean, 40.5 months, range, 25-70 months), the mean volume reduction rate was 85.3% (SD ± 12.2). Local symptoms improved from 2.9 (SD ± 2.0) to 0.3 (SD ± 0.8) on a 10-point scale (P < .001), and the mean cosmetic score decreased from 3.6 (SD ± 0.9) to 1.6 (SD ± 0.9) (P < .001). Three patients (7.5%) experienced temporary hoarseness; no other adverse events were reported. CONCLUSIONS: RF ablation is an effective, repeatable treatment for multinodular goiter, achieving substantial symptom and cosmetic improvement while preventing nodule regrowth and avoiding thyroid surgery in selected patients.